Experimental animal models of muscle wasting in intensive care unit patients.
The muscle wasting and loss of muscle function associated with critical illness and intensive care have significant negative consequences for weaning from the respirator, duration of hospital stay, and quality of life for long periods after hospital discharge. There is, accordingly, a significant demand for focused research aiming at improving our understanding of the mechanisms underlying the impaired neuromuscular function in intensive care unit (ICU) patients. However, the study of generalized muscle weakness in critically ill ICU patients is further complicated by the coexistence of multiple independent factors, such as different primary diseases, large variability in pharmacologic treatment, collection of muscle samples several weeks after admission to the ICU, and exposure to causative agents. This has led to the design of specific animal models mimicking ICU conditions. These models have often been used to study the mechanisms underlying the paralysis and muscle wasting associated with acute quadriplegic myopathy in ICU patients. This short review aims at presenting existing and recently introduced experimental animal models mimicking the conditions in the ICU (i.e., models designed to determine the mechanisms underlying the muscle wasting associated with ICU treatment).
Larsson
Lars
L
Department of Clinical Neurophysiology, Uppsala University Hospital, Uppsala, Sweden. Lars.Larsson@neurofys.uu.se
D000818:Animals; D016638:Critical Illness; D004195:Disease Models, Animal; D007362:Intensive Care Units; D018908:Muscle Weakness / Q000209:etiology; D009133:Muscular Atrophy / Q000209:etiology; D011782:Quadriplegia / Q000150:complications; D019282:Wasting Syndrome / Q000209:etiology